Skip to main content
Figure 1 | BMC Nephrology

Figure 1

From: Prognostic utility of plasma S100A12 levels to establish a novel scoring system for predicting mortality in maintenance hemodialysis patients: a two-year prospective observational study in Japan

Figure 1

Kaplan–Meier estimates of two-year survival by baseline plasma S100A12 levels. The median value of plasma S100A12 levels of all participants at baseline were 18.79 ng/mL. The participants were divided into a lower S100A12 group (solid line) and a higher S100A12 group (dotted line) according to this median value (χ2 = 10.239, P = 0.001 by the log-rank test).

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us